Effect of intensive lipid-lowering therapy on inflammatory factors and fibrinolytic system in patients with acute cerebral infarction

Acute cerebral infarction is a common disease in the middleAged and old[1]. In particular, with the development of population aging, the morbidity of acute cerebral infarction is more and more higher[2]. As the disability rate and recurrence rate of acute cerebral infarction is high[3], it can bring a heavy burden to the family and society. So the prevention and treatment of acute cerebral infarction is extremely important. This study investigates the effects of atorvastatin calcium on the inflammatory factors and fibrinolytic system in patients with acute cerebral infarction, in order to provide a theoretical basis for clinical treatment.